Literature DB >> 24038401

Model building in nonproportional hazard regression.

Mar Rodríguez-Girondo1, Thomas Kneib, Carmen Cadarso-Suárez, Emad Abu-Assi.   

Abstract

Recent developments of statistical methods allow for a very flexible modeling of covariates affecting survival times via the hazard rate, including also the inspection of possible time-dependent associations. Despite their immediate appeal in terms of flexibility, these models typically introduce additional difficulties when a subset of covariates and the corresponding modeling alternatives have to be chosen, that is, for building the most suitable model for given data. This is particularly true when potentially time-varying associations are given. We propose to conduct a piecewise exponential representation of the original survival data to link hazard regression with estimation schemes based on of the Poisson likelihood to make recent advances for model building in exponential family regression accessible also in the nonproportional hazard regression context. A two-stage stepwise selection approach, an approach based on doubly penalized likelihood, and a componentwise functional gradient descent approach are adapted to the piecewise exponential regression problem. These three techniques were compared via an intensive simulation study. An application to prognosis after discharge for patients who suffered a myocardial infarction supplements the simulation to demonstrate the pros and cons of the approaches in real data analyses.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  boosting; generalized additive models; model choice; penalized likelihood; piecewise exponential model; survival analysis; variable selection

Mesh:

Year:  2013        PMID: 24038401     DOI: 10.1002/sim.5961

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  1 in total

1.  Boosting multi-state models.

Authors:  Holger Reulen; Thomas Kneib
Journal:  Lifetime Data Anal       Date:  2015-05-20       Impact factor: 1.588

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.